Oh look, https://www.thisismoney.co.uk/money/cars/article-9540603/Toyota-Mirai-review-second-generation-hydrogen-fuel-cell-car.html the 60pence a mile fuel cost of the first Toyota mirai's is down to 15 pence a mile.. That's a huge reduction. Itm power is the only electrolyser mentioned here in this positive story.
If you combine a modest fuel cell with a battery, the battery can charge when driving slower, in our crowded roads, and the low internal resistance of a li ion battery can give you tesla-like acceleration when you like. Then when you end up slower because of the car in front, the mcdonalds stop, etc, your fuel cell can totally silently charge your able-to-be-smaller hybrid at its max capacity...imagine though a small gas turbine (like the https://www.autocar.co.uk/car-news/green-cars/deltas-micro-turbine-range-extender-will-make-production-2019-model or the one BLADON jets are making for land rover/jaguar prototypes) screaming away in mcdonalds drive through. And so filthy too. No to gas turbine range extenders, yes to small hydrogen tank and small cheap fuel cell...
>>So it's not JUST range anxiety, but it's also "will it work anxiety".
- I endorse that as an EV owner. You need so many app's and often the fast charger you header for is not working and you call the helpline and they try to remotely reboot it and can't. It's crazy. Zapmap says it's working, you read the ZM comments too, rely on it and it's OOS. I've ended up on 7kW chargers for hours (adds 25 miles of range per hour). But, I have a tesla. I got lucky with a long trip to Swaffham over weekend and Lincs. There are more superchargers now. More teslas too. Charged at M11 Bishops Stortford. There, I could only connect to the rightmost of all the chargers – the only one vacant – by parking sideways on, lead wasn’t quite long enough as charger port is to right when view car from front. Shared with one other car (two leads from one stall) and I found it wouldn’t give me any charger until he left; first-comer has all capacity. The moment he disconnected, which only took 5 minutes, I was able to charge. Kings Lynn now has a supercharger too, and so does Wyboston on the way back, so I didn’t have to divert from my intended track to charge. Total charging stops (3 of them) added to 100 minutes cumulative stop time across the journey. I selected tesla charger as destination so it knew to precondition the battery (told me it was doing this) meaning I charged at up to 90 kW (otherwise it only takes at 30 kW), though often 50 to 60. Even tesla charging adds a fair bit to your journey. Would have been more but the last stop I only added enough to get home with 50 miles left, and then charged it for 24 hours solid at 2 kW (sometimes 1 kW; when hot weather, home charge current drops periodically from 10a to 5a because the slow charger overheats, and goes even slower, until I get my 7 kW type 2 menekes) as home 14 p/kWh Tesla 25 p/kWh. Other fast chargers mostly 33p or 35p, the worst are IONITY at 69p. Shell allows its franchisees to choose between 39 to 69p and some nasty little fascists choose 69p. I hate that for contactless on some fast chargers they add a 20% premium compared to the app. Petrol's not like that !! I hate the non-interoperability, so I can't charge from the Chademo chargers on the M3, and I can only take at 11 KW from a 3 phase type 2 AC menekes meant to be 22 kW capable, like the free one at Swaffham Tesco (but no car except a zoe can take at 22 kW, and most zoe's can't take rom any DC fast charger...). I must say the cost of hydrogen for motoring needs to come down a lot, that's why there are no private sales of the Toyota Mirai yet. But it WILL come down a lot, obviously. At the moment it comes out at 65 pence a mile marginal motoring cost in the Mirai, which is why I got the tesla for less than the capex of the mirai !!!
A hydrogen car IS an EV, as the wheel motors are electric; it's just that the electrons are stored via hydrogen as the energy vector. It's a very efficient way to store energy. And you can still have a battery and charge off the mains when you are able to, away from home or at home; a smaller battery (see lithium and cobalt crisis story below) is possible as the fuel cell becomes your range extender, operating in parallel with battery discharge to greatly extend range even if capacity of FC << wheel motor max power. A FC can be pretty small.
I saw this : https://www.independent.co.uk/climate-change/news/critical-minerals-electric-cars-renewables-b1841942.html and thought of ITM Power and fuel cell'd vehicles with smaller batteries.
The report is at : https://www.iea.org/reports/the-role-of-critical-minerals-in-clean-energy-transitions
"In a scenario that meets the Paris Agreement goals, clean energy technologies’ share of total demand rises significantly over the next two decades to over 40% for copper and rare earth elements, 6070% for nickel and cobalt, and almost 90% for lithium. EVs and battery storage have already displaced consumer electronics to become the largest consumer of lithium and are set to take over from stainless steel as the largest end user of nickel by 2040." Wow. Says bad things about Chinese dominance of Cobalt (for Li-Ion cells as used in EVs so far), too.
Having said that, I must admit don't know what sort of metals are used as the catalyst in our ITM power world-leading electrolysers.
https://www.independent.co.uk/climate-change/news/critical-minerals-electric-cars-renewables-b1841942.html Investment in critical minerals used in electric cars and renewables falling ‘well short’ of what is needed, says International Energy Agency
In a scenario that meets the Paris Agreement goals, clean energy technologies’ share of total demand rises significantly over the next two decades to over 40% for copper and rare earth elements, 6070% for nickel and cobalt, and almost 90% for lithium. EVs and battery storage have already displaced consumer electronics to become the largest consumer of lithium and are set to take over from stainless steel as the largest end user of nickel by 2040.
I think a perceived problem might be that this £30m contract went to Porton Down and it could have gone to Open Orph.
The government is investing almost £30m in expanding laboratories that will assess the effectiveness of vaccines against emerging coronavirus variants. Jenny Harries, chief executive at the UK Health Security Agency, said: “A new variant that can escape the current vaccines is the greatest risk of a third wave. This new investment will help us stay one step ahead of the virus by doubling our capacity to challenge vaccine effectiveness against emerging variants."
- it is NOT, mind you, the construction of a human challenge trial laboratory. But it is work that Open / its subsidiary could have been funded to carry out (as could other firms).
Oh, final point. A firm I know well as a good friend works for it, recently sold a business unit that wasn't a separate firm. The novation agreements to novate 50 odd contracts (an agreement with the counterparty to each contract) from the parent to the business unit that had to be quickly created as a separate firm, to which all contracts had to be novated, took 6 months. You cannot achieve a quick sale of a business unit when the day comes, it may never of course .. or one day in the years to come it may, when someone makes you a very generous offer, if it is not already a legally separate firm at that time. By contrast if it is already a legally separate firm, you just send a letter to the counterparty saying we are same firm same company number, but now owned by XYZ [and where relevant, we renamed the firm]. It's that simple as long as you keep the same company number (with some nice comms about how the contract will still be delivered, in fact even better than before of course). If it is already a legally separate firm, in selling it you do need to agree which staff are sold with it and TUPE them across. But that's relatively OK to do.
So having a legally separate firm makes work for accountants, for sure, filing separate accounts, but gives future optionality and carries no hazard, as long as you have enough accountants. It can in some cases help give business focus too, compared to the internal business unit that ITM Motive was before; or may have no effect there.
Take a very large pan-national firm that I invest in, ****. It has ~~50 separate UK subsidiaries that it wholly owns. Each has its own "board". Look at the board members. They are drawn from small subset of directors of main firm's UK board. I know that the separation is not that complete and they work seamlesly with the parent. There is no legal obligation (other than for certain regulated companies, like network firms; example NGESO) for the separation to be observed; no chinese walls are needed and staff may work both on the subsidiaries' projects and the parents or other subsidiaries, mixing their time seamlessly. This true of most really large firms. ITM's market cap has grown a lot. This hiving-off into separate firms is normal, and makes accounting clearer plus allows quicker and easier sale of business units later if they want to and get a good offer.
I don't think we should abuse those who aren't positive. That sort of chat room is a complete waste of bandwidth and puts me off reading it. I sometimes post on the boards of shares I no longer own, and that's fine. There's no rule that you have to own a share, or have any financial interest at all in it, to enjoin discussion about it. As to Zoe, I did think the last RNS was really good, and don't understand why she's fallen. A lot of AIM shares seem to have fallen over the last week, though not all this much. It's usually not MM manipulation, nor do I care whether any particular buys and sells are categorised correctly. It's the ebb and flow of sentiment in us lot that drives shares up and down, and there often doesn't seem much rhyme and reason to it. Example Nano, nothing really changed but suddenly she's miles up on a month ago. Doesn't matter. Will, I hope, happen to us too soon enough; Zoe issues fairly regular RNSs (compared to say, Eden, where you wait 4 months at a time sometimes). For me Zoe is a buy at today's price (except my other shares are down too, and seem to also have good upside, so I don't want to sell them to fund more Zoe).
Negative posters are welcome, to test our thinking. We can each reach our own conclusion on what we believe, and trying to bully/scare them off just makes for a BB that no sensible person wishes to read at all.
The NHS database most certainly has verified vaccinations with batch number, where given, and a note on any allergies declared by the patient or other relevant matters declared just before the shot. As data inputter at a vacc centre, I know this. Their IT support is surprisingly excellent, which you might not expect from a state monolith. You have to tick a consent given field ahead of passing them on to be vaccinated. There is an ethnicity field too but that is not mandatory.
>>Would someone kindly sum at where we’re at right now, and what we’re now waiting on?
- phase 3 trials that cost £80m have ended, at some point they publish something after reviewing the data. We don't know when. The indian covid variant (main one) appears vaccine-evading, and the PM speaks (yesterday, 5:15 pm BST) of a new focus on cures/ameliorants with a task force force to identify the best one. This seems like good news for Synairgen, but isn't in the price today. I have 12 AIM shares and all but one are down today. Travel shares have been falling as well as CINE and covid cure shares and covid test shares like ODX; some of those should be counter-cyclical, but the ruddy lot are down, so are RR and some main shares. I am holding the lot. Not selling anything at a low; that more often is a matter of regret, than not.
Yes I get the impression that the Indian variant is vaccine-immunity-evasive in a way that the SA variant isn't. Hence the softening up for an enhanced "booster" in autumn, "live with the virus" (can't lockdown forever) and a new focus on cures. The two leading cures in terms of not just incremental but potentially radical reductions in death rates are Synairgen's beta inteferon inhaler and foralumab. He spoke of possible oral intake; well, foralumab can be delivered orally, and synairgen you just sniff. With us ending phase 2 trials (or ended them - any ideas?) and synairgen ending or ended £80m worth of phase 3, I expect both to get a lift out of this.
I expect you all saw the undercover TV documentary last week or two of the PCR testing lab where workers were filmed under cover ignoring known cross-pollution of adjacent cells and just ploughing on to meet management targets, at one lab. No idea whose PCR tests they were. It was a sloppy lab issue really.